Harvard Apparatus Regenerative Technology Inc.
HRGN
$1.08
-$0.04-3.57%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 704.00K | 743.00K | 679.00K | 418.00K | 430.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 704.00K | 743.00K | 679.00K | 418.00K | 430.00K |
| Cost of Revenue | 646.00K | 622.00K | 580.00K | 291.00K | 270.00K |
| Gross Profit | 58.00K | 121.00K | 99.00K | 127.00K | 160.00K |
| SG&A Expenses | 4.37M | 4.54M | 4.77M | 5.00M | 5.14M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.62M | 7.33M | 7.41M | 7.29M | 7.66M |
| Operating Income | -6.92M | -6.58M | -6.73M | -6.88M | -7.23M |
| Income Before Tax | -6.87M | -6.53M | -6.69M | -7.36M | -7.73M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -6.87 | -6.53 | -6.69 | -7.36 | -7.73 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.87M | -6.53M | -6.69M | -7.36M | -7.73M |
| EBIT | -6.92M | -6.58M | -6.73M | -6.88M | -7.23M |
| EBITDA | -6.91M | -6.58M | -6.72M | -6.87M | -7.21M |
| EPS Basic | -0.42 | -0.40 | -0.43 | -0.49 | -0.53 |
| Normalized Basic EPS | -0.26 | -0.25 | -0.27 | -0.28 | -0.31 |
| EPS Diluted | -0.42 | -0.40 | -0.43 | -0.49 | -0.53 |
| Normalized Diluted EPS | -0.26 | -0.25 | -0.27 | -0.28 | -0.31 |
| Average Basic Shares Outstanding | 66.06M | 64.80M | 62.78M | 61.12M | 59.15M |
| Average Diluted Shares Outstanding | 66.06M | 64.80M | 62.78M | 61.12M | 59.15M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |